Remicade was hailed as a wonder drug for rheumatoid arthritis and Crohn's disease when it was licensed for use six years ago. It was such a wonder drug, in fact, that sufferers in Canada were lobbying doctors to prescribe it, and psoriasis sufferers were praying for the day when it could be approved for them to use as well.
This was a surprisingly warm reception for a drug that could bring on TB among susceptible patients. And that welcome may go down to gas mark one with the news that Remicade can also cause fatal blood and neurological disorders.
These latest reactions have been included in a letter sent out to health professionals in the USA at the insistence of the Food and Drug Administration (FDA), the US drugs watchdog. Any patient on the drug who has a persistent fever should seek immediate medical attention, the manufacturer urges.
Next wonder drug, please.